C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/15 (2006.01) A61K 38/57 (2006.01) C07K 14/81 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2092920
2092920 9206111 PCTABS00011 An aprotinin analogue with reduced nephrotoxicity, wherein, to provide a reduced positive net charge, at least one positively charged amino acid residue outside the protease-binding site is removed or replaced with a neutral or negatively charged amino acid residue, and/or wherein at least one negatively charged amino acid residue is inserted or added, and/or wherein at least one neutral amino acid residue is replaced with a negatively charged amino acid residue, and/or wherein, to provide reduced stability, one or more amino acid residues are deleted, added or replaced with one or more other amino acid residues.
Bjorn Soren E.
Bregengaard Claus
Christensen Niels D.
Diness Viggo
Norris Kjeld
Mccarthy Tetrault Llp
Novo Nordisk A/s
LandOfFree
Aprotinin analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aprotinin analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aprotinin analogues will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1373575